Skip to main content
logo
Seelos Therapeutics, Inc. (SEELQ)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Nov 3, 2025, 3:48 PM EST

Seelos Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Nov '25 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Market Capitalization
014731728436
Market Cap Growth
-80.03%-81.29%-57.68%103.72%133.74%-
Enterprise Value
-2864957621
Last Close Price
0.00177.922607.366259.216067.215145.61

Price Ratios

Fiscal Year
CurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Nov '25 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
PS Ratio
0.006.18---96.30
PB Ratio
--0.41-6.863.0032.82-5158.84
P/TBV Ratio
---3.0032.82-

EV Ratios

Fiscal Year
CurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Nov '25 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
EV/Sales Ratio
-12.68---55.46

Financial Efficiency

Fiscal Year
CurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Nov '25 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Debt / Equity Ratio
-0.36-0.42-1.900.333.78-
Net Debt / Equity Ratio
-0.35-0.33-0.43-1.04-2.311465.86
Net Debt / EBITDA Ratio
-----0.37
Asset Turnover
0.280.16---0.07
Quick Ratio
0.020.100.629.502.110.95
Current Ratio
0.080.140.9010.072.361.03
Return on Equity (ROE)
---314.84%-220.55%-1489.36%-
Return on Assets (ROA)
-261.11%-179.75%-83.43%-76.33%-82.02%-307.29%
Return on Capital Employed (ROCE)
106.00%120.90%2940.10%-82.00%-186.40%-8725.50%

Yields

Fiscal Year
CurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Nov '25 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Earnings Yield
3008088.24%-278.25%-101.06%-38.41%-22.63%-141.93%
Buyback Yield / Dilution
-191.24%-38.20%-17.04%-103.03%--